258 related articles for article (PubMed ID: 18176767)
21. Severe acneiform eruption induced by cetuximab (Erbitux).
Lee JE; Lee SJ; Lee HJ; Lee JH; Lee KH
Yonsei Med J; 2008 Oct; 49(5):851-2. PubMed ID: 18972607
[TBL] [Abstract][Full Text] [Related]
22. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.
Jacot W; Bessis D; Jorda E; Ychou M; Fabbro M; Pujol JL; Guillot B
Br J Dermatol; 2004 Jul; 151(1):238-41. PubMed ID: 15270903
[No Abstract] [Full Text] [Related]
23. Malassezia folliculitis presented as acneiform eruption after cetuximab administration.
Cholongitas E; Pipili C; Ioannidou D
J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376
[TBL] [Abstract][Full Text] [Related]
24. Papulo-pustular eruption during cetuximab treatment.
Satta R; Cuccuru MA; Pirodda C; Cottoni F
G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
[No Abstract] [Full Text] [Related]
25. [Acneiform skin eruption in patients with metastatic colorectal carcinoma].
Gethöffer K; Schneider LA; Peters T; Weber L; Scharffetter-Kochanek K
Hautarzt; 2006 Jul; 57(7):628-31. PubMed ID: 16034631
[No Abstract] [Full Text] [Related]
26. Acneiform eruption induced by cetuximab.
Cotena C; Gisondi P; Colato C; Girolomoni G
Acta Dermatovenerol Croat; 2007; 15(4):246-8. PubMed ID: 18093454
[TBL] [Abstract][Full Text] [Related]
27. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
Shin JU; Park JH; Cho BC; Lee JH
Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507
[TBL] [Abstract][Full Text] [Related]
28. A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption.
Scope A; Lieb JA; Dusza SW; Phelan DL; Myskowski PL; Saltz L; Halpern AC
J Am Acad Dermatol; 2009 Oct; 61(4):614-20. PubMed ID: 19646778
[TBL] [Abstract][Full Text] [Related]
29. Ecthymatous skin eruption during therapy with cetuximab.
Navarini AA; Kamacharova I; Kerl K; Donghi D; Cozzio A
Eur J Dermatol; 2011; 21(2):282-3. PubMed ID: 21489913
[No Abstract] [Full Text] [Related]
30. [Acneiform eruption secondary to cetuximab with pseudomalignant histopathological changes].
Vidal-Olmo I; Bassas-Vila J; Herrera-Acosta E; Umbert-Millet P
Actas Dermosifiliogr; 2008 Mar; 99(2):159-60. PubMed ID: 18346444
[No Abstract] [Full Text] [Related]
31. Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions.
Chiang HC; Anadkat MJ
J Am Acad Dermatol; 2013 Oct; 69(4):657-8. PubMed ID: 24034378
[No Abstract] [Full Text] [Related]
32. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.
DeWitt CA; Siroy AE; Stone SP
J Am Acad Dermatol; 2007 Mar; 56(3):500-5. PubMed ID: 17166623
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Tumor Response to Cetuximab and Panitumumab in 116 Patients and a Review of Approaches to Managing Skin Toxicity.
Jaka A; Gutiérrez-Rivera A; López-Pestaña A; del Alcázar E; Zubizarreta J; Vildosola S; Arregui MA; Sarasqueta C; Lobo C; Tuneu A
Actas Dermosifiliogr; 2015; 106(6):483-92. PubMed ID: 25798804
[TBL] [Abstract][Full Text] [Related]
34. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Scope A; Agero AL; Dusza SW; Myskowski PL; Lieb JA; Saltz L; Kemeny NE; Halpern AC
J Clin Oncol; 2007 Dec; 25(34):5390-6. PubMed ID: 18048820
[TBL] [Abstract][Full Text] [Related]
35. Complications of therapy and a diagnostic dilemma case. Case 2. Cutaneous toxicity induced by cetuximab.
Monti M; Mancini LL; Ferrari B; Rahal D; Santoro A
J Clin Oncol; 2003 Dec; 21(24):4651-3. PubMed ID: 14673056
[No Abstract] [Full Text] [Related]
36. [Unilateral acneiform rash in facial palsy].
Kerob D; Hennequin V; Bousquet G; Behm E; Lebbe C
Ann Dermatol Venereol; 2010 Nov; 137(11):727-9. PubMed ID: 21074658
[TBL] [Abstract][Full Text] [Related]
37. Common side effects of anti-EGFR therapy: acneform rash.
Sipples R
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):28-34. PubMed ID: 16616284
[TBL] [Abstract][Full Text] [Related]
38. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Sheu J; Hawryluk EB; Litsas G; Thakuria M; LeBoeuf NR
Clin Breast Cancer; 2015 Feb; 15(1):e77-81. PubMed ID: 25445421
[No Abstract] [Full Text] [Related]
39. Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor.
Fernandez-Galar M; España A; López-Picazo JM
Clin Exp Dermatol; 2004 Mar; 29(2):138-40. PubMed ID: 14987267
[TBL] [Abstract][Full Text] [Related]
40. Perifollicular xanthomas associated with epidermal growth factor receptor inhibitor therapy.
Eames T; Kroth J; Flaig MJ; Ruzicka T; Wollenberg A
Acta Derm Venereol; 2010 Mar; 90(2):202-3. PubMed ID: 20169314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
